FDA Approved: INTRAROSA — Supplemental Application (Millicent US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for INTRAROSA (prasterone) by Millicent US, Inc., signaling regulatory approval of a supplemental/label change for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause

Drugs mentioned

• Intrarosa (prasterone)

Snippet

SUPPL AP for INTRAROSA (PRASTERONE)